相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI
Xuelei Song et al.
International Journal of Biological Sciences (2012)
Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages
Lesley E. Smythies et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
Tissue-Specific Liver X Receptor Activation Promotes Macrophage Reverse Cholesterol Transport In Vivo
Tomoyuki Yasuda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
L-4F Alters Hyperlipidemic (But Not Healthy) Mouse Plasma to Reduce Platelet Aggregation
Georgette M. Buga et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
Laurent Yvan-Charvet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
High plasma lecithin: cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: Possible attenuation of cardioprotection associated with high HDL cholesterol
Robin P. F. Dullaart et al.
ATHEROSCLEROSIS (2010)
Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT
Menno Vergeer et al.
ATHEROSCLEROSIS (2010)
Intestinal Specific LXR Activation Stimulates Reverse Cholesterol Transport and Protects from Atherosclerosis
Giuseppe Lo Sasso et al.
CELL METABOLISM (2010)
Structure/Function Relationships of Apolipoprotein A-I Mimetic Peptides Implications for Antiatherogenic Activities of High-Density Lipoprotein
Wilissa D'Souza et al.
CIRCULATION RESEARCH (2010)
Impact of Combined Deficiency of Hepatic Lipase and Endothelial Lipase on the Metabolism of Both High-Density Lipoproteins and Apolipoprotein B-Containing Lipoproteins
Robert J. Brown et al.
CIRCULATION RESEARCH (2010)
Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial
Evan A. Stein et al.
EUROPEAN HEART JOURNAL (2010)
Seeing red: flushing out instigators of niacin-associated skin toxicity
Richard L. Dunbar et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice
Julien Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?
Jean-Claude Tardif
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
Plasma levels of lecithin: cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study
A. G. Holleboom et al.
JOURNAL OF LIPID RESEARCH (2010)
A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice
John K. Bielicki et al.
JOURNAL OF LIPID RESEARCH (2010)
Biochemical characterization of cholesteryl ester transfer protein inhibitors
Mollie Ranalletta et al.
JOURNAL OF LIPID RESEARCH (2010)
Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport
Eric J. Niesor et al.
JOURNAL OF LIPID RESEARCH (2010)
RVX-208 A Small Molecule That Increases Apolipoprotein A-I and High-Density Lipoprotein Cholesterol In Vitro and In Vivo
Dana Bailey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis) Final Results and the Impact of Medication Adherence, Dose, and Treatment Duration
Todd C. Villines et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
A First-in-Man, Randomized, Placebo-Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High-Density Lipoprotein Plasma Infusions in Patients With Acute Coronary Syndrome
Ron Waksman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease.
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oxpholipin 11D: An Anti-Inflammatory Peptide That Binds Cholesterol and Oxidized Phospholipids
Piotr Ruchala et al.
PLOS ONE (2010)
D-4F, an Apolipoprotein A-I Mimetic Peptide, Promotes Cholesterol Efflux from Macrophages via ATP-Binding Cassette Transporter A1
Qiong Xie et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib
Christopher P. Cannon et al.
AMERICAN HEART JOURNAL (2009)
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients
Daniel Bloomfield et al.
AMERICAN HEART JOURNAL (2009)
The Pharmacology and Off-Target Effects of Some Cholesterol Ester Transfer Protein Inhibitors
Menno Vergeer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Lessons Learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
Philip Barter
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease
Dorbie Maccubbin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Macrophage Reverse Cholesterol Transport in Mice Expressing ApoA-I Milano
Eric T. Alexander et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Liver X receptor modulators: Effects on lipid metabolism and potential use in the treatment of atherosclerosis
C. Fievet et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitors
Krista B. Goodman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans
Laura Calabresi et al.
CIRCULATION (2009)
Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux
Anna C. Calkin et al.
CIRCULATION (2009)
Lecithin: Cholesterol Acyltransferase and Atherosclerosis Another High-Density Lipoprotein Story That Doesn't Quite Follow the Script
Daniel J. Rader
CIRCULATION (2009)
Lecithin: Cholesterol Acyltransferase Expression Has Minimal Effects on Macrophage Reverse Cholesterol Transport In Vivo
Hiroyuki Tanigawa et al.
CIRCULATION (2009)
Apolipoprotein A-I Mimetic Peptides
Brian J. Van Lenten et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations
Majken K. Jensen et al.
EUROPEAN HEART JOURNAL (2009)
Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo
Frank M. Sacks et al.
JOURNAL OF LIPID RESEARCH (2009)
Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes
Sanjay Patel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and apoB-containing lipoproteins
Stefania Lamon-Fava et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone
M. J. Forrest et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cholesteryl Ester Transfer Protein (CETP) Inhibitors: Is There Life After Torcetrapib?
Hemanth Neeli et al.
CARDIOLOGY CLINICS (2008)
Endothelial lipase is increased in vivo by inflammation in humans
Karen O. Badellino et al.
CIRCULATION (2008)
Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis Insights From ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation)
Stephen J. Nicholls et al.
CIRCULATION (2008)
Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
James A. Shaw et al.
CIRCULATION RESEARCH (2008)
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk
Alexander Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans
Eseng Lai et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2008)
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I
Brian J. Van Lenten et al.
JOURNAL OF LIPID RESEARCH (2008)
Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
LeAnne T. Bloedon et al.
JOURNAL OF LIPID RESEARCH (2008)
Dose-related effects of repeated ETC-216 (recombinant apolipoprotein A-IMilano/1-palmitoyl-2-oleoyl phosphatidylcholine complexes) administrations on rabbit lipid-rich soft plaques -: In vivo assessment by intravascular ultrasound and magnetic resonance imaging
Cinzia Parolini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Beyond high-density lipoprotein cholesterol levels - Evaluating high-density lipoprotein function as influenced by novel therapeutic approaches
Emil M. deGoma et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Protective effect of an endothelial lipase gene variant on coronary artery disease in a Chinese population
Na-Ping Tang et al.
JOURNAL OF LIPID RESEARCH (2008)
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies
Rajesh Krishna et al.
LANCET (2007)
Liver X receptor and farnesoid X receptor as therapeutic targets
Daniel J. Rader
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport
Hiroyuki Tanigawa et al.
CIRCULATION (2007)
Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and efflux
Ginny L. Weibel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRα and apoE
Michelle N. Bradley et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial
Michiel L. Bots et al.
LANCET (2007)
Nicotinic acid receptor agonists differentially activate downstream effectors
Jeremy G. Richman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits
Lee A. Morehouse et al.
JOURNAL OF LIPID RESEARCH (2007)
Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
Corinna Lebherz et al.
CARDIOVASCULAR DIABETOLOGY (2007)
Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL
Laurent Yvan-Charvet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Optimal medical therapy with or without PCI for stable coronary disease
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides
Susanna E. Borggreve et al.
EUROPEAN HEART JOURNAL (2007)
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
G. M. Anantharamaiah et al.
JOURNAL OF LIPID RESEARCH (2007)
Molecular regulation of HDL metabolism and function: implications for novel therapies
Daniel J. Rader
JOURNAL OF CLINICAL INVESTIGATION (2006)
Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice
Lai Wang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Liver X receptor (LXR)-β regulation in LXRα-deficient mice:: Implications for therapeutic targeting
Elaine M. Quinet et al.
MOLECULAR PHARMACOLOGY (2006)
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: A population-based study
Susanna E. Borggreve et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway
F Matsuura et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Intestinal ABCA1 directly contributes to HDL biogenesis in vivo
LR Brunham et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Different roles of liver X receptor α and β in lipid metabolism:: Effects of an α-selective and a dual agonist in mice deficient in each subtype
EG Lund et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis
KO Badellino et al.
PLOS MEDICINE (2006)
Apolipoprotein A-I and the molecular variant apoA-IMilano:: Evaluation of the antiatherogenic effects in knock-in mouse model
C Parolini et al.
ATHEROSCLEROSIS (2005)
Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages
E Rigamonti et al.
CIRCULATION RESEARCH (2005)
Compromised LCAT function is associated with increased atherosclerosis
GK Hovingh et al.
CIRCULATION (2005)
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice
M Navab et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo
GF Qi et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with Pravastatin in type II dyslipidemia
JA Kuivenhoven et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits
SJ Nicholls et al.
CIRCULATION (2005)
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice
XJ Li et al.
CIRCULATION (2004)
Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women - The prospective EPIC (European Prospective Investigation into Cancer and Nutrition) - Norfolk population study
SM Boekholdt et al.
CIRCULATION (2004)
Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2 - A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
AJ Taylor et al.
CIRCULATION (2004)
ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis
FG Schaap et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
M Navab et al.
JOURNAL OF LIPID RESEARCH (2004)
The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c
H Jakel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antiinflammatory properties of HDL
PJ Barter et al.
CIRCULATION RESEARCH (2004)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo
YZ Zhang et al.
CIRCULATION (2003)
Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor
T Inaba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice - LCAT gene transfer decreases atherosclerosis
A Mertens et al.
CIRCULATION (2003)
Molecular identification of high and low affinity receptors for nicotinic acid
A Wise et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
S Tunaru et al.
NATURE MEDICINE (2003)
Endothelial lipase: a new lipase on the block
SY Choi et al.
JOURNAL OF LIPID RESEARCH (2002)
Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles
A Grefhorst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency -: Veterans Affairs HDL Cholesterol Intervention Trial
ME Brousseau et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Causes of interscan variability of coronary artery calcium measurements at electron-beam CT
B Lu et al.
ACADEMIC RADIOLOGY (2002)
Recombinant apolipoprotein A-IMilano infusion into rabbit carotid artery rapidly removes lipid from fatty streaks
G Chiesa et al.
CIRCULATION RESEARCH (2002)
Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans - A randomized phase II dose-response study
GJ de Grooth et al.
CIRCULATION (2002)
Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol
M Navab et al.
CIRCULATION (2002)
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
BG Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
High-dose recombinant apolipoprotein A-IMilano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein E-deficient mice -: Potential implications for acute plaque stabilization
PK Shah et al.
CIRCULATION (2001)
Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter
T Yoshikawa et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice
S Alberti et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
JJ Repa et al.
GENES & DEVELOPMENT (2000)
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
H Okamoto et al.
NATURE (2000)
Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis
S Santamarina-Fojo et al.
CURRENT OPINION IN LIPIDOLOGY (2000)
Serial quantitative coronary angiography and coronary events
WJ Mack et al.
AMERICAN HEART JOURNAL (2000)
Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk -: The Framingham study
JM Ordovas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Structural characterisation of the mouse nuclear oxysterol receptor genes LXRα and LXRβ
S Alberti et al.
GENE (2000)
Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis
CW Rittershaus et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
